Drugs / GTL001
last change Aug 2016 re-read 2 minutes ago

GTL001

Vaccine

Investigated by
Genticel · PPD Development, LP

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02689726 Aug 2015 → Aug 2016 Genticel Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GTL001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02689726
Modality Vaccine “GTL001 VaccineNCT02689726